RXST Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.13% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	1.14M
Vidutinė apimtis	410 825
Rinkos kapitalizacija	2.35B
EPS	$-0.250 ( Q1 \| 2024-05-06 )
Kita pelno data	( $-0.110 ) 2024-08-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-48.52 (Sector) 42.63 (Industry) 0
ATR14	$0.0820 (0.14%)

AEMD -13.81%

AFIB -13.41%

AHCO 1.42%

AHPI 0.00%

ALGN -0.65%

ANIK -1.52%

APEN 0.00%

APYX -4.96%

ARAY 1.68%

ATEC 0.58%

AXDX 1.74%

AXGN 0.28%

AXNX -0.25%

AZYO 2.05%

BBLG 0.83%

BIOL 38.50%

BJDX -6.77%

BMRA -2.16%

BRKR -0.61%

BSGM -5.35%

BWAY 0.83%

CERS 0.57%

CFMS 0.44%

CLPT -5.11%

CODX -1.57%

CSII 0.15%

CTKB 1.64%

CTSO -9.00%

CUTR 3.42%

CVRX 2.48%

DCTH 1.70%

DXCM -1.01%

DYNT -20.97%

EAR -4.10%

ECOR -0.16%

EDAP 4.21%

ESTA 3.56%

FONR 1.46%

HJLI -1.98%

HSDT -1.99%

HSKA 0.00%

HYPR -11.00%

IART 1.36%

ICAD 0.00%

ICCM -1.99%

IINN -2.13%

INGN 2.01%

INMD 1.00%

IRIX 0.00%

IRMD -0.05%

IRTC 3.12%

ISO 0.00%

ITMR 0.00%

KIDS -0.10%

LHDX 0.00%

LIVN -0.02%

LNSR 2.74%

LUCD -5.64%

LUNG 2.76%

MASS 0.00%

MDGS 10.28%

MOTS 0.17%

MOVE -3.51%

MSON 0.00%

NAOV -5.41%

NARI 2.47%

NMRD 0.00%

NNOX 10.71%

NPCE 8.00%

NTUS 0.00%

NURO 0.27%

NUVA -2.24%

NUWE 18.57%

NVCN 0.00%

NVNO 1.55%

OBLN -5.86%

OFIX -1.63%

OM -7.00%

PACB 0.74%

PAVM 6.30%

PETV 0.00%

PODD -2.50%

PRCT 2.28%

PROF -4.88%

QIPT 3.54%

QTRX 1.62%

RCEL -0.38%

RPID -4.90%

RSLS -3.23%

RWLK 6.07%

RXST 1.81%

SGHT 1.99%

SIBN 4.02%

SIEN -18.69%

SILK 0.52%

SINT -6.98%

SOLY 0.00%

SRDX 0.17%

SRGA 0.00%

SRTS 1.72%

SWAV 0.00%

TBIO -8.29%

TCMD 3.20%

TELA -8.56%

THMO 9.52%

TIVC -1.02%

TLIS 0.72%

TMCI 0.15%

TMDI 0.00%

TMDX 1.89%

TNDM -0.35%

TNON 0.00%

UFPT 2.41%

VERO -2.71%

VIVE 0.00%

VMD 1.24%

VRAY 0.00%

VREX 0.75%

VVOS -7.11%

XAIR -7.38%

XENT 0.00%

ZIMV 3.75%

Insider Trading

Date	Person	Action	Amount	type
2024-06-14	Andrews Julie	Sell	11 940	Common Stock
2024-06-14	Andrews Julie	Sell	3 685	Common Stock
2024-06-06	Warner Robert Keith	Buy	2 554	Common Stock
2024-06-06	Palmisano Robert J	Buy	2 554	Common Stock
2024-06-06	Maniar Shweta	Buy	2 554	Common Stock

INSIDER POWER
5.90
Last 100 transactions
Buy: 668 683 \| Sell: 609 612

Koreliacija (AI algo v.1.1b): Undervalued: 0.13% $60.24 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.48 (neutral)

Trumpas: 0.18 (neutral)

Signal:(62.227) Neutral

RxSight, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
TUR	0.882
CGEM	0.876
STEP	0.858
INBKZ	0.855
APXI	0.842
SILK	0.833
BDTX	0.832
INTE	0.829
HYAC	0.823
OXSQ	0.822

10 Labiausiai neigiamai susiję koreliacijos
UTRS	-0.907
GLBS	-0.878
SBAC	-0.867
WINT	-0.862
NAVI	-0.856
EGBN	-0.853
SSBI	-0.853
WVVIP	-0.849
RVSB	-0.847
IGOV	-0.844

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

RxSight, Inc. Koreliacija - Valiuta/Žaliavos

0.09
( neutral )

-0.07
( neutral )

0.00
( neutral )

0.16
( neutral )

0.00
( neutral )

0.09
( neutral )

RxSight, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$89.08M
Bruto pelnas:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2023
Pajamos:	$89.08M
Bruto pelnas:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2022
Pajamos:	$49.01M
Bruto pelnas:	$21.33M (43.52 %)
EPS:	$-2.41

FY	2021
Pajamos:	$22.59M
Bruto pelnas:	$4.52M (19.99 %)
EPS:	$-2.59

Financial Reports:

No articles found.

RxSight, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.